VTRS Viatris Inc: רווח למניה בשנים עשר החודשים האחרונים

The 12-month YoY EPS percentage change provided by GURU.Markets shows a current figure of 82.50. This trend reflects aggressive debt reduction through the sale of non-core assets. Time-tested drugs ensure a stable cash flow, despite partial portfolio erosion. Viatris Inc. (VTRS) revenues are based on the mass production of well-known generics and complex biosimilars.
Mylan - פילוחים אנליטיים ומדדי מפתח (VTRS)

The operational efficiency of Viatris Inc. (VTRS) is reflected through the historical EPS YoY TTM delta. This indicator captures the growth rate of the rolling annual earnings per share, measuring the net income dynamics over a 12-month period. The metric's growth confirms the resilience of generic margins despite pricing pressure from competitors. A stable value for this indicator suggests predictable cash flows and high asset quality for the company.